104 related articles for article (PubMed ID: 5861506)
1. A clinical study of wintomylon in the treatment of shigellosis.
Yu PC; Chen HS
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
[No Abstract] [Full Text] [Related]
2. [Treatment of bacillary dysentery with Wintomylon].
Ishikawa J
Nihon Densenbyo Gakkai Zasshi; 1967 Mar; 40(12):460-2. PubMed ID: 4962909
[No Abstract] [Full Text] [Related]
3. Antibiotics in the management of shigellosis.
Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
[No Abstract] [Full Text] [Related]
4. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
Fernandez LA
J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
[No Abstract] [Full Text] [Related]
5. International note. Antibiotics in the management of shigellosis.
Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
[No Abstract] [Full Text] [Related]
6. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
Haltalin KC; Nelson JD; Kusmiesz HT
Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
[TBL] [Abstract][Full Text] [Related]
7. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
Mahmood A
J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
[No Abstract] [Full Text] [Related]
8. Drug resistant shigellosis in south India.
Paniker CK; Vimala KN; Bhat P; Stephen S
Indian J Med Res; 1978 Sep; 68():413-7. PubMed ID: 744630
[No Abstract] [Full Text] [Related]
9. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
[TBL] [Abstract][Full Text] [Related]
10. Nalidixic acid for shigellosis.
Parry HE
Lancet; 1983 Nov; 2(8360):1206. PubMed ID: 6139566
[No Abstract] [Full Text] [Related]
11. Nalidixic acid in resistant shigella infection.
Agrawal ML; Mukherjee SP; Prasad SS
J Assoc Physicians India; 1987 May; 35(5):390. PubMed ID: 3693298
[No Abstract] [Full Text] [Related]
12. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
Niyogi SK; Mitra U; Dutta P
Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
[No Abstract] [Full Text] [Related]
14. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and antibiotic resistance of Shigella gastroenteritis in Ankara, Turkey between 2003 and 2009, and comparison with previous reports.
Özmert EN; İnce OT; Örün E; Yalçın S; Yurdakök K; Gür D
Int J Infect Dis; 2011 Dec; 15(12):e849-53. PubMed ID: 21982814
[TBL] [Abstract][Full Text] [Related]
17. [Combined therapy of methacolimycin (sodium colistin methanesulfonate) and Wintomylon (nalidixic acid) in bacillary dysentery].
Tajime H; Hirayama A; Takayama Y; Imagawa Y
Nihon Densenbyo Gakkai Zasshi; 1968 Mar; 41(12):445-9. PubMed ID: 4971073
[No Abstract] [Full Text] [Related]
18. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
[TBL] [Abstract][Full Text] [Related]
19. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
Cheasty T; Day M; Threlfall EJ
Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
[TBL] [Abstract][Full Text] [Related]
20. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
Salam MA; Bennish ML
J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
